Ian Chi Kei Wong
Ian Chi Kei Wong publishes mostly in Cardiology and Cardiovascular Medicine, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health, on topics such as Pharmaceutical studies and practices, Attention Deficit Hyperactivity Disorder and SARS-CoV-2 and COVID-19 Research.
- World rank
- #95,405 of 7,710,434 ranked researchers
- Rank in China
- #8,153 of 978,568
- Works
- 1,155
- Citations
- 32k
- Citations per work
- 27.7
What does Ian Chi Kei Wong research?
Ian Chi Kei Wong's work is mostly in Medicine (38%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else71161.6%
- Health Sciences44438.4%
- Medicine44438.4%
- 1Cardiology and Cardiovascular Medicine8% of their works
- 2Pediatrics, Perinatology and Child Health7% of their works
- 3Psychiatry and Mental health7% of their works
- 4Infectious Diseases6% of their works
- 5Surgery5% of their works
- 6Epidemiology5% of their works
Research topics
- Pharmaceutical studies and practices
- Attention Deficit Hyperactivity Disorder
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Atrial Fibrillation Management and Outcomes
- Pharmaceutical Practices and Patient Outcomes
- Pharmacovigilance and Adverse Drug Reactions
- Diabetes Treatment and Management
Which keywords describe Ian Chi Kei Wong's research?
The keywords of their largest research topics: Adverse Drug Reactions, ACE2 Receptor, SARS-CoV-2, Off-Label Drug Use, Pediatric Pharmacokinetics, ADHD, Attention-Deficit/Hyperactivity Disorder and Coronavirus.
- Cardiovascular Outcomes
- Pharmacovigilance
- Inappropriate Medication Use
- Anticoagulant Therapy
- Clinical Characteristics
- Coronavirus
- ADHD
- Off-Label Drug Use
- ACE2 Receptor
- Adverse Drug Reactions
- SARS-CoV-2
- Pediatric Pharmacokinetics
- Attention-Deficit/Hyperactivity Disorder
- Vaccine
- Epidemiology
- Atrial Fibrillation
- Polypharmacy
- Signal Detection
- Type 2 Diabetes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Adverse Drug Reactions1832 topics
- ACE2 Receptor1612 topics
- SARS-CoV-21612 topics
- Off-Label Drug Use1281 topic
- Pediatric Pharmacokinetics1281 topic
- ADHD921 topic
- Attention-Deficit/Hyperactivity Disorder921 topic
- Coronavirus851 topic
- Vaccine851 topic
- Clinical Characteristics761 topic
- Epidemiology761 topic
- Anticoagulant Therapy671 topic
- Atrial Fibrillation671 topic
- Inappropriate Medication Use661 topic
- Polypharmacy661 topic
- Pharmacovigilance551 topic
- Signal Detection551 topic
- Cardiovascular Outcomes431 topic
- Type 2 Diabetes431 topic
Where does Ian Chi Kei Wong work?
Ian Chi Kei Wong's main affiliation in the publication record is University of Hong Kong, China.
How many publications and citations does Ian Chi Kei Wong have?
OpenAlex counts 1,155 works and 32,050 citations for Ian Chi Kei Wong, an h-index of 87, ranking #95,405 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ian Chi Kei Wong. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.